![AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER](https://mma.prnewswire.com/media/152881/amgen_logo.jpg?p=twitter)
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
![Amgen Eager for Regulatory Discussions After Lumakras-Vectibix CodeBreaK 300 Data in Colon Cancer | Precision Medicine Online Amgen Eager for Regulatory Discussions After Lumakras-Vectibix CodeBreaK 300 Data in Colon Cancer | Precision Medicine Online](https://crain-platform-precisiononcologynews-prod.s3.amazonaws.com/styles/800x600/s3/GettyImages-1386027971.jpg)
Amgen Eager for Regulatory Discussions After Lumakras-Vectibix CodeBreaK 300 Data in Colon Cancer | Precision Medicine Online
![LUMAKRAS (sotorasib) tablets | Price & Cost | Pharma Network Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA LUMAKRAS (sotorasib) tablets | Price & Cost | Pharma Network Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA](https://medvitaz.com/wp-content/uploads/2021/07/lumakras.jpg)
LUMAKRAS (sotorasib) tablets | Price & Cost | Pharma Network Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA
![Combination Therapy More Than Doubles Survival in Patients With Metastatic Colorectal Cancer Compared to Standard of Care Combination Therapy More Than Doubles Survival in Patients With Metastatic Colorectal Cancer Compared to Standard of Care](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/01fc196ed1d9f6232007c3e10f773bbc7d38e617-986x664.png?fit=crop&auto=format)